XPELCER Trademark

Trademark Overview

On Wednesday, October 21, 2020, a trademark application was filed for XPELCER with the United States Patent and Trademark Office. The USPTO has given the XPELCER trademark a serial number of 90268715. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 25, 2024. This trademark is owned by Alexion Pharmaceuticals, Inc.. The XPELCER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of metabolic disorders
xpelcer

General Information

Serial Number90268715
Word MarkXPELCER
Filing DateWednesday, October 21, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 22, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of metabolic disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 9, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlexion Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameAlexion Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Saturday, October 24, 2020NEW APPLICATION ENTERED
Wednesday, December 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 22, 2021ASSIGNED TO EXAMINER
Tuesday, March 23, 2021PRIORITY ACTION WRITTEN
Tuesday, March 23, 2021PRIORITY ACTION E-MAILED
Tuesday, March 23, 2021NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, May 13, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 13, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 13, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 13, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 2, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 22, 2021PUBLISHED FOR OPPOSITION
Tuesday, June 22, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 17, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 24, 2022SOU TEAS EXTENSION RECEIVED
Monday, January 24, 2022SOU EXTENSION 1 FILED
Monday, January 24, 2022SOU EXTENSION 1 GRANTED
Thursday, August 4, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, January 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 4, 2022SOU EXTENSION 2 FILED
Thursday, August 4, 2022SOU EXTENSION 2 GRANTED
Saturday, August 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 17, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 13, 2022ASSIGNED TO EXAMINER
Friday, January 13, 2023SOU TEAS EXTENSION RECEIVED
Friday, January 13, 2023SOU EXTENSION 3 FILED
Friday, January 13, 2023SOU EXTENSION 3 GRANTED
Tuesday, January 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 17, 2023SOU EXTENSION 4 FILED
Monday, July 17, 2023SOU EXTENSION 4 GRANTED
Wednesday, July 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 25, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, March 25, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

xpelcer disorders metabolic treatment preparations pharmaceutical